v1
Should high risk patients with Hodgkin's disease be singled out for heavier therapeutic regimens while low risk patients are spared such therapies?
Identifier:nobleid.org/w1/20260515/13DF538F
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/13DF538F)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors